(Date:11/20/2008)...achMD, the first satellite radio,channel created ..., announced,today their newest strategic programm...rs Association (AMDA), the professional associatio... others practicing in the long term care,continuu... AMDA says, "ReachMD provides a,great opportunity...
(Date:11/20/2008)...Bloomberg School of Public Health and The New York...m to mark the 60th Anniversary of the Universal De...th and Human Rights: The Work Ahead of Us," will e... over the last 60 years. , Navanethem Pillay, SJ...uman Rights will be the keynote speaker. , Adopt...
(Date:11/20/2008)...ov. 20 /PRNewswire/ Bayer HealthCare,has donated ...of New Jersey,(CFBNJ) in response to an urgent ca...ical companies to help restock supplies at the sta...com.com/cgi-bin/prnh/20081120/NETH138 ) , Mary..., and Anne King,manager, Field Communications, w...
(Date:11/20/2008)... Precyse Solutions, the leader in,driving peak He...ugh,technology and management solutions, was reco...ylvania as "Technology Company of the Year" at the...nter. The Annual Gala honors the,region,s top te...eurs. More,than 1200 business leaders attended t...
Breaking Medicine News(10 mins):Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2Health News:Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governor's Plea to Help the State's Population in Need 2Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2(Date:11/20/2008)... EMERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCal...he company will present results from the Phase 1B,...dvanced metastatic breast,cancer, BZL101, at the ...onal,Conference in Atlanta, Georgia. The Company...g abstract and will be presented as a part of the ...
(Date:11/20/2008)... CAMBRIDGE, Mass., Nov. 20 Radius...sed an additional $15 million to its second instit... investment to $82.5 million and the total amount ...lion. All existing institutional investors partici...tegic Fund and including MPM Capital, The Wellcome...
(Date:11/20/2008)... BOSTON, Nov. 20 PAREXE...eading global biopharmaceutical services provider,...ima, Peru to provide regulatory consulting and cli...the Peru office, PAREXEL now has locations through...tin America, which also include Argentina, Brazil,...
(Date:11/19/2008)... SAN FRANCISCO, Nov. 19 Posit Sci...d evidence at the Society for Neuroscience,Annual... that cognitive,training may benefit Baby Boomers...Fitness Program (TM) uses adaptive exercises that ...ses are designed to drive generalized,improvement...
Breaking Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 1New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 2New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 3New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 4New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 5New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 6New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 7New Data Support High Complete Remission Rates With VELCADE 28R 29 28Bortezomib 29 for Injection Based Therapies in Patients With Newly Diagnosed Mul 2105 8New E health recommendations from ACP aim to improve health care quality safety and access 19616 1New E health recommendations from ACP aim to improve health care quality safety and access 19616 2World AIDS Vaccine Day 2008 19613 1World AIDS Vaccine Day 2008 19613 2World AIDS Vaccine Day 2008 19613 3World AIDS Vaccine Day 2008 19613 4Message to Michigan Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19610 1Message to Michigan Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19610 2Message to Michigan Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 19610 3...opharm plc (LSE: PYM) ("Phytopharm" or the "Compan... Cogane(tm) reverses the,changes in the area of th... will be presented by Dr Jonathan Brotchie, an,int...ase at ,The,11th International Congress of Parkins...anbul, Turkey and published in The Movement,Disord...
...tein 90 Inhibitor,Reveal Further Evidence of Safet...GE, Mass. and GAITHERSBURG, Md., June 5, 2007 (PRI...sdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) today...clinical trial of the companies, heat shock,protei...relapsed,refractory gastrointestinal stromal tumo...
Other Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7Speculum can be used for any type of eye surgery. Arms of speculum lie flat due to joint between blade and arms. Features quick locking mechanism.
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm.
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 15 mm.
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches.
Medicine Products: